# DALFAMPRIDINE
> **ANDA206863** · Abbreviated New Drug Application (Generic) · Sponsor: ACCORD HLTHCARE · Approved 2018-07-11
## Drug
- **FDA Application Number:** ANDA206863
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DALFAMPRIDINE
- **Generic name:** DALFAMPRIDINE
- **Active ingredients:** DALFAMPRIDINE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ACCORD HLTHCARE
- **Manufacturer:** Accord Healthcare Inc.
- **First approval:** 2018-07-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206863)
---
*MORVS · CC0 1.0*